HECT E3 Ubiquitin Ligase Assay Bypassing System
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The complexity of the E1→E2→E3 ubiquitination cascade, particularly the need for ATP, E1, and E2 enzymes, makes it difficult to study and develop therapeutics targeting protein ubiquitination, especially for E3 enzymes like HECT E3s, which are crucial but challenging to assay due to their biochemical properties.
Innovation Solution
A bypassing system (ByS) that utilizes C-terminal ubiquitin thioesters to directly react with HECT E3 enzymes, such as Rsp5, to form catalytically active thioesters, enabling ubiquitination of protein substrates and polyubiquitin chain synthesis without ATP or E2 enzymes, and using small molecule thiols as E2 enzyme mimics to facilitate efficient autoubiquitination and isopeptide bond formation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the native E1→E2→E3 ubiquitination cascade is used, then the physiological relevance is maintained, but the assay complexity increases due to requiring ATP, E1, E2 enzymes, and multiple protein subunits
Solution Approach 1:
The patent extracts and removes the E1 and E2 enzymes from the ubiquitination cascade, creating a simplified system that uses only the E3 enzyme and chemically activated ubiquitin thioesters. This extraction maintains the essential E3 catalytic function while eliminating the complexity of requiring multiple enzymes and ATP, directly resolving the contradiction between physiological relevance and assay complexity
Solution Approach 2:
The patent segments the ubiquitination process into two distinct parts: (1) chemical activation of ubiquitin via C-terminal thioester formation using small molecule thiols, and (2) E3-catalyzed transfer to substrates. This segmentation allows the complex E1-E2 activation steps to be replaced by simple chemical reactions, reducing assay complexity while preserving E3 enzymatic activity measurement
2Reliability
If multiple protein subunits are assembled to form functional E3 enzymes, then the native enzyme structure is preserved, but the ease of operation decreases due to assembly requirements
Solution Approach 1:
The patent employs self-assembling peptide substrates containing ubiquitin-binding motifs that automatically interact with E3 enzymes upon mixing. This self-service mechanism eliminates the need for manual assembly of multi-subunit E3 complexes, as the substrate spontaneously organizes with the E3 enzyme to form the functional complex, greatly improving ease of operation while maintaining structural integrity
3Ease of operation
If C-terminal ubiquitin thioesters are used to bypass E1 and E2 enzymes, then the assay simplicity increases, but the measurement precision may be affected by deviation from native conditions
Solution Approach 1:
The patent changes the activation state of ubiquitin from the native ATP-dependent E1-E2 activated form to a chemically activated C-terminal thioester form. This parameter change allows direct measurement of E3 catalytic activity without the confounding variables of E1-E2 enzyme kinetics and ATP consumption, improving measurement precision for E3-specific studies while maintaining assay simplicity
Solution Approach 2:
The patent introduces small molecule thiols as intermediaries to form C-terminal ubiquitin thioesters, which then serve as the actual substrate for E3 enzymes. This intermediary approach bypasses the complex E1-E2 system while providing a well-defined, stable substrate that enables precise measurement of E3 activity under simplified conditions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This system simplifies the study of protein ubiquitination, allows for the development of assays to discover pharmacological modulators of E3 enzymes, and demonstrates that E2 enzymes are dispensable for K63-specific isopeptide bond formation, providing a general mechanism for understanding and manipulating protein ubiquitination processes.
Implementation Method 1
C-terminal ubiquitin thioesters can undergo a direct transthiolation reaction with the catalytic cysteine of the model HECT E3 ubiquitin ligase Rsp5 and form a catalytically active Rsp5 ̃Ub thioester
Implementation Method 2
The resulting Rsp5 ̃Ub thioester undergoes efficient autoubiquitination, ubiquitinates protein substrates, and synthesizes polyubiquitin chains with specific isopeptide linkages
Implementation Method 3
small molecule thiols, such as glutathione can act as E2 enzyme mimics in the native E1→E2→E3 ubiquitination cascade, leading to the efficient E3 enzyme autoubiquitination
Data Source
AI summary
Provided herein is technology relating to the biological process of protein ubiquitination and particularly, but not exclusively, to compositions and methods for studying protein ubiquitination and developing therapeutics to modulate protein ubiquitination.